Advertisement
Screener

ENvue Medical, Inc. (FEED) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate

ENvue Medical, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate

ENvue Medical, Inc. (FEED) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 3.58% for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2022-11-14

  • ENvue Medical, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2022-03-31 was 2.32%, a 373.47% increase year-over-year.
  • ENvue Medical, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2021-03-31 was 0.49%.
  • ENvue Medical, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2019-03-31 was 2.79%.
  • ENvue Medical, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2015 was 0.00%, a 100.00% decline from fiscal 2014.
  • ENvue Medical, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2014 was 1.73%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month
2022-09-303.58%
10-Q · filed 2022-11-14
2022-06-302.32%
10-Q · filed 2022-08-15
2022-03-312.32%
10-Q · filed 2022-05-16
2021-09-300.49%
10-Q · filed 2022-11-14
2021-06-300.49%
10-Q · filed 2022-08-15
2021-03-310.49%
10-Q · filed 2022-05-16
2020-06-300.34%
10-Q/A · filed 2020-08-24
2019-03-312.79%
10-Q · filed 2020-07-06
2016-09-301.21%
10-Q · filed 2016-11-14
2015-12-310.00%
10-K · filed 2016-03-30
2014-12-311.73%
10-K · filed 2016-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Bone Biologics Corp (BBLG)United States$0.001B
Lifeward Ltd. (LFWD)$0.021B
LogicMark, Inc. (LGMK)United States$0.000B
MILESTONE SCIENTIFIC INC. (MLSS)United States$0.036B-6.85
ALPHA PRO TECH LTD (APT)$0.052B13.63
Envoy Medical, Inc. (COCH)United States$0.056B
MYOMO, INC. (MYO)United States$0.065B-2.85
Safe Pro Group Inc. (SPAI)United States$0.090B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
NutriBand Inc. (NTRB)United States$0.109B